In his closing thoughts, Dr Gordon discusses navigation of treatment resistance in DLBCL management.
Diffuse Large B-Cell Lymphoma Guideline Updates 2023 | videos
The impact of collaborative care in DLBCL treatment is explored by a medical expert.
Treatment of DLBCL amid comorbidities in elderly patients is highlighted.
Dr Gordon discusses use of bispecifics for management of patients with relapsing DLBCL.
Dr Gordon provides strategies for navigating treatment-associated toxicities in DLBCL management as directed by NCCN Guidelines.
A medical expert examines first6, second-, and third-line systemic therapies for DLBCL in accordance with NCCN Guidelines.
Key recommendations and recent updates in the latest version of NCCN guidelines for DLBCL are outlined by Dr Gordon.
Leo Gordon, MD, provides an overview of current treatment strategies currently driven by NCCN guidelines.
Advertisement
Advertisement
Trending on AJMC
1
ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity
2
Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment
3
CMS Proposes Permanent Rules for Medicare Drug Price Negotiation
4
CKD Stage, Proteinuria Tied to Higher HCRU in IgAN
5